-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Lowered to $15 at Benchmark
-
-
-
-
-
-
-
Unicycive resubmits drug application for kidney disease treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
-
-
-
-
-
-
-
Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
-
-
-
-
-
-
-
Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) Announces U.S. FDA Acceptance of the NDA for Oxylanthanum Carbonate
-
-
-
-
-
15,508 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

